FMR LLC 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:17 am Sale | 2025-09-30 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 9,283,773 8.100% | -2,246,033 (-19.48%) | Filing |
| 2025-08-07 10:06 am Purchase | 2025-07-31 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 11,529,806 10.300% | 1,690,630 (+17.18%) | Filing |
| 2025-08-06 11:44 am Purchase | 2025-06-30 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 9,839,176 8.800% | 4,191,183 (+74.21%) | Filing |
| 2025-05-07 10:55 am Sale | 2025-04-30 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 5,647,993 5.200% | -9,035,879 (-61.54%) | Filing |
| 2025-05-07 10:40 am Sale | 2025-03-31 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 14,683,872 13.000% | -3,047,397 (-17.19%) | Filing |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 17,731,269 16.252% | 4,683,939 (+35.90%) | Filing |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,047,330 12.658% | 4,154,232 (+46.71%) | Filing |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 8,893,098 8.780% | -4,385,709 (-33.03%) | Filing |
| 2022-02-09 09:07 am Sale | 2022-02-08 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,278,807 13.594% | -467,707 (-3.40%) | Filing |
| 2021-12-10 08:52 am Sale | 2021-12-09 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,746,514 14.059% | -2,915,302 (-17.50%) | Filing |
| 2021-02-08 10:13 am Purchase | 2021-02-05 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 16,661,816 19.207% | 4,520,624 (+37.23%) | Filing |